Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Merck KGaA    MRK   DE0006599905

MERCK KGAA

(MRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Merck : Precigen Shares Gain 20% as Germany's Merck Raises Stake

10/09/2020 | 10:24am EST

By Colin Kellaher

Shares of Precigen Inc. rose more than 20% on Friday after Germany's Merck KGaA raised its stake in the biopharmaceutical company.

Precigen said Merck, its second-largest shareholder, opted to convert a $25 million note into common stock early, boosting its stake in the Germantown, Md., company to 14.8% from 11.6%.

Precigen shares were recently up 20.6% to $5.32.

Write to Colin Kellaher at colin.kellaher@wsj.com

(END) Dow Jones Newswires

10-09-20 1023ET

Stocks mentioned in the article
ChangeLast1st jan.
MERCK KGAA 0.34% 133.85 Delayed Quote.27.05%
PRECIGEN, INC. 5.74% 7.92 Delayed Quote.44.53%
All news about MERCK KGAA
11/30MERCK KGAA : Gets a Buy rating from Kepler Cheuvreux
MD
11/26MERCK : Partners With Siemens on New Plant
DJ
11/24Deutsche Bank's Depositary Receipts Virtual Investor Conference presentations..
AQ
11/24MERCK KGAA : Correction of a release from 25/03/2020 according to Article 40, Se..
EQ
11/23MERCK : Massachusetts-based Businesses of Merck KGaA, Darmstadt, Germany named t..
AQ
11/23MERCK KGAA : Release according to Article 40, Section 1 of the WpHG [the German ..
EQ
11/19MERCK : EMD Serono's Embracing Carers Announces Study Results on COVID-19 and Ca..
AQ
11/17MERCK KGAA : UBS reiterates its Neutral rating
MD
11/16MERCK KGAA : Goldman Sachs keeps a Sell rating
MD
11/16MERCK KGAA : JP Morgan remains Neutral
MD
More news
Financials
Sales 2020 17 381 M 20 783 M 20 783 M
Net income 2020 2 013 M 2 407 M 2 407 M
Net Debt 2020 11 224 M 13 421 M 13 421 M
P/E ratio 2020 28,7x
Yield 2020 1,05%
Capitalization 58 195 M 69 553 M 69 585 M
EV / Sales 2020 3,99x
EV / Sales 2021 3,71x
Nbr of Employees 58 077
Free-Float 29,7%
Chart MERCK KGAA
Duration : Period :
Merck KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MERCK KGAA
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 135,37 €
Last Close Price 133,85 €
Spread / Highest target 26,3%
Spread / Average Target 1,13%
Spread / Lowest Target -24,5%
EPS Revisions
Managers
NameTitle
Stefan Oschmann Chairman-Executive Board & CEO
Wolfgang Heinz Büchele Chairman-Supervisory Board
Marcus Kuhnert Chief Financial Officer
Christian Raabe Independent Member-Supervisory Board
Edeltraud Glänzer Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
MERCK KGAA27.05%69 553
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD91.48%19 549
KYOWA KIRIN CO., LTD.10.88%14 873
BETTA PHARMACEUTICALS CO., LTD.39.54%5 557
YUHAN CORPORATION38.05%3 709
RECIPHARM AB (PUBL)19.91%1 868